Your Catalyst To a Lucrative Business
Genital warts , HPV , HIV , and hepatitis genital herpes are examples of STIs caused by viruses . These microorganisms get transmitted through semen , blood , and vaginal fluids . Chlamydia is by far the most commonly occurring sexually transmitted disease . In terms of revenues , this segment held the highest share in the overall industry . It generated revenues surpassing USD 36 billion in 2016 . However , rising cases of syphilis may contribute to more than 20 % of total industry revenues over the forecast period ( 2016 to 2024 ). Based on location of tests , the market is bifurcated into laboratory testing and point of care ( PoC ) testing . Laboratory tests are carried out either in public health labs or in private / commercial labs . Unlike , PoC testing solutions , laboratory tests deliver more precise results . PoC tests ( such as test kits ) are a more convenient option because these deliver immediate results , but they are not always accurate . The introduction of bedside & mobile testing is a step towards enhanced healthcare . The industry for bedside & mobile testing may expand at a CAGR nearly 10 % from 2016 to 2024 .
According to type of device , the worldwide STD diagnostics market is segmented into thermal cyclers - PCRs , lateral flow readers , flow cytometers , differential light scattering machines , absorbance microplate reader , phone chips ( microfluidics + ICT ), and bench top / portable / rapid diagnostics kits . Portable / rapid diagnostics and phone chips are PoC testing devices , while the others are laboratory test devices . The thermal cyclers segment is anticipated to grow rapidly at a CAGR surpassing 8 % during the forecast period . The portable PoC testing devices industry is propelled by continuous technological innovations . It may generate revenues exceeding USD 46 billion by 2024 .
Geographically , the global STD diagnostics market is divided into Asia Pacific , North Amer ica , Latin America , Europe , and the Middle East & Africa . Driven by surging public awareness about STIs and the presence of a well developed system of health insurance , North America dominates the global industry . Another vital factor that positively impacts this region is the growing accessibility to FDA-approved highly advanced testing devices . As per ongoing industry trends , Asia Pacific may register a high CAGR over the forecast period and thus prove to be a lucrative market in the long run . Prominent companies operating in the worldwide STD diagnostics market are Danaher Corporation , Abbott Laboratories , BioMerieux , Roche Holdings AG , and Becton Dickinson & Company .
Recently , QuantuMDx , a U . K . based company dealing in life sciences diagnostics & tools , developed the Q- Poc . This is a highly affordable diagnostic DNA analyzer which is commonly known as the “ handheld lab ”. It is capable of diagnosing certain types of cancers and a number of infectious diseases ( including the sexually transmitted ones ). Equipped with a solar battery , the Q-Poc can analyze biological samples , for example , swabs are used to detect sexually transmitted diseases / infections . Browse Related Category Market Reports @ https :// www . hexaresearch . com / research-category / clinicaldiagnostics-industry
Follow Us :